FIELD: gynecological endocrinology. SUBSTANCE: one introduces thyroid hormones, for instance L-thyroxin, in maximum tolerable doses during 3 to 12 months and determines therapeutic efficiency from integrated estimation of mastopathy remission. After termination of the course, enzyme or vitamin therapy is performed. When mastalgia is observed, one orders therapy designed to correct failed function of endocrine glands revealed during complex examination before treatment taking into account data obtained during examination of woman after treatment. EFFECT: enabled partial remission of endocrinal organs and complete mastopathy remission with restoration of lutein phase of ovulatory ovary cycle. 2 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING CHRONIC ANOVULATION AND PREVENTING SYNDROME OF OVARIAN HYPERSTIMULATION | 1999 |
|
RU2201225C2 |
METHOD FOR EVALUATING THYROID DYSFUNCTION TREATMENT EFFECTIVENESS | 2004 |
|
RU2289139C2 |
METHOD OF TREATMENT OF WOMEN WITH ACNE DISEASE | 1998 |
|
RU2148994C1 |
METHOD FOR PREDICTING AUTOIMMUNE OOPHORITIS OF INFLAMMATORY GENESIS IN WOMEN OF REPRODUCTIVE AGE | 2006 |
|
RU2312359C1 |
METHOD FOR SELECTING PREGNANT WOMEN DURING I-II TRIMESTERS FOR CARRYING OUT THE CORRECTING THERAPY OF THYROID DYSFUNCTION | 2005 |
|
RU2297794C1 |
METHOD OF TREATING HYPOTHYROIDISM | 2009 |
|
RU2407533C1 |
METHOD OF TREATMENT FOR AUTOIMMUNE OOPHORITIS OF INFLAMMATION GENESIS FOR WOMEN OF CHILDBEARING AGE | 2008 |
|
RU2370278C1 |
METHOD FOR DIFFERENTIAL DIAGNOSTICS OF DIFFERENT AUTOIMMUNE THYROID LESIONS | 2006 |
|
RU2315322C1 |
METHOD FOR PREDICTING THE RISK OF REPRODUCTIVE DISORDERS IN WOMEN WITH SUBCLINICAL AND OVERT HYPOTHYROIDISM | 2022 |
|
RU2804212C1 |
METHOD FOR ANTENATAL PROPHYLAXIS OF HEALTH DISORDERS IN NEONATALS | 2004 |
|
RU2277917C2 |
Authors
Dates
2001-08-27—Published
2000-05-11—Filed